scholarly journals Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia

2017 ◽  
Vol 10 (1) ◽  
Author(s):  
Federica Mastroiacovo ◽  
Slavianka Moyanova ◽  
Milena Cannella ◽  
Anderson Gaglione ◽  
Remy Verhaeghe ◽  
...  
2010 ◽  
Vol 31 (4) ◽  
pp. 1107-1118 ◽  
Author(s):  
Slavianka G Moyanova ◽  
Federica Mastroiacovo ◽  
Lidia V Kortenska ◽  
Rumiana G Mitreva ◽  
Erminia Fardone ◽  
...  

We examined the influence of type 4 metabotropic glutamate (mGlu4) receptors on ischemic brain damage using the permanent middle cerebral artery occlusion (MCAO) model in mice and the endothelin-1 (Et-1) model of transient focal ischemia in rats. Mice lacking mGlu4 receptors showed a 25% to 30% increase in infarct volume after MCAO as compared with wild-type littermates. In normal mice, systemic injection of the selective mGlu4 receptor enhancer, N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-caboxamide (PHCCC; 10 mg/kg, subcutaneous, administered once 30 minutes before MCAO), reduced the extent of ischemic brain damage by 35% to 45%. The drug was inactive in mGlu4 receptor knockout mice. In the Et-1 model, PHCCC administered only once 20 minutes after ischemia reduced the infarct volume to a larger extent in the caudate/putamen than in the cerebral cortex. Ischemic rats treated with PHCCC showed a faster recovery of neuronal function, as shown by electrocorticographic recording and by a battery of specific tests, which assess sensorimotor deficits. These data indicate that activation of mGlu4 receptors limit the development of brain damage after permanent or transient focal ischemia. These findings are promising because selective mGlu4 receptor enhancers are under clinical development for the treatment of Parkinson's disease and other central nervous system disorders.


2004 ◽  
Vol 92 (2) ◽  
pp. 838-844 ◽  
Author(s):  
Huan-Xin Chen ◽  
Steven N. Roper

Maturation of many synapses of the CNS is characterized by a reduction in initial release probability and associated alterations in short-term plasticity (STP). We investigated the role of tonic activity of metabotropic glutamate receptors (mGluRs) in this process in glutamatergic synapses of rat neocortex. Consistent with previous reports, STP of excitatory postsynaptic currents (EPSCs) evoked by five-pulse stimulation was found to switch from depression at postnatal days 13–17 (P13–17) to facilitation at postnatal days 28–42 (P28–42). (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine, a specific mGluR2/3 agonist, strongly depressed EPSCs both at the early stage and the late stage of cortical development. This was accompanied by a switch from depression to facilitation of STP at the early stage and an increase in facilitation at the late stage. While application of 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl) propanoic acid ( LY341495 ), an mGluR antagonist that is most potent at mGluR2/3, had no significant effect at the early stage, it significantly enhanced EPSC amplitude and reduced short-term facilitation at the late stage. Blocking glutamate transporter activity with l- trans-pyrrolidine-2,4-dicarboxylate (tPDC) significantly reduced EPSC amplitude and short-term depression in the younger group but had no effect in the older specimens. The effect of tPDC was blocked by LY341495. These results suggest that a progressive increase in tonic mGluR activity during postnatal development contributes to a reduction of release probability in excitatory cortical synapses. They also indicate that glutamate transporter activity in the neocortex decreases during postnatal development. This may play a role in increasing tonic activity of mGluRs by increasing ambient glutamate levels in the perisynaptic extracellular space.


Sign in / Sign up

Export Citation Format

Share Document